Rigel Pharmaceuticals Inc (RIGL)
Gross Profit Growth
-27.79%
Quarterly · Period ending:
RIGL Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported-27.79%period ending
Latest reported-27.79%period ending
RIGL Quarterly Gross Profit YoY % (20.23% → -27.79%)
Year-over-year change
High-resolution chart · PNG
RIGL gross profit growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Gross Profit Growth |
|---|---|
| -27.7863% | |
| 10.8086% | |
| 23.2401% | |
| 36.8605% | |
| 185.5409% | |
| 77.8472% | |
| 61.8868% | |
| 75.9882% | |
| 31.8585% | |
| 9.6282% | |
| -37.1721% | |
| 21.2365% | |
| -10.3255% | |
| 51.0353% | |
| 155.6771% | |
| 3.5901% | |
| 10.1236% | |
| -79.4131% | |
| 9.8902% | |
| 17.2229% | |
| 66.0335% | |
| 45.1318% | |
| 19.0974% | |
| -11.1841% | |
| 55.9231% | |
| 344.2438% | |
| -59.5901% | |
| 328.4195% | |
| 474.6158% | |
| 211.3414% | |
| 425.8282% | |
| 148.4053% | |
| 115.2464% | |
| -27.8662% | |
| -33.9009% | |
| 20.1676% | |
| -29.8625% | |
| 33.1102% | |
| -7.5754% | |
| -395.4491% | |
| 10.1367% | |
| 2.8098% | |
| -26.1355% | |
| 84.4901% | |
| 50.78% | |
| 19.8293% | |
| 48.2515% | |
| 8.0972% | |
| -11.5045% | |
| 16.9628% | |
| 37.7859% | |
| 12.9397% | |
| -1,299.5333% | |
| -2,808.6667% | |
| -563.5132% | |
| 279.7468% | |
| 100% | |
| -93.975% | |
| -99.2013% | |
| -100% | |
| -16,766.6667% | |
| -100% | |
| -100% | |
| -100% | |
| 155.7545% | |
| -100% | |
| -86.3417% | |
| -73.2848% | |
| -48.0399% | |
| 86.6849% | |
| 210.9205% | |
| 278.0367% | |
| 447.2727% | |
| 398.0273% | |
| 209.7512% | |
| 76.0592% | |
| -47.7683% | |
| -68.6638% | |
| -36.6965% | |
| -66.9335% | |
| -43.0811% | |
| -42.4309% | |
| -45.8381% | |
| 9.7365% | |
| -6.6128% | |
| -13.1479% | |
| 38.8729% | |
| 2.169% | |
| 23.4268% | |
| 26.0791% | |
| -6.3849% | |
| 20.2338% |